Release Date: 18/02/14 08:38 Summary: Half Year Report and Accounts Price Sensitive: Yes Download Document 250.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%